The comparison of effectiveness of religious cognitive behavior therapy and classic cognitive behavior therapy and repetitive transcranial magnetic stimulation (rTMS) on anhedonia, rumination with their related neural circuits in patients with major depression
Comparison of the effectiveness of psychological treatment methods (classical and religious cognitive-behavioral therapy) and repetitive transcranial magnetic stimulation (rTMS) on anhedonia, rumination and neural networks associated with each of them
Design
Clinical trials with control group with randomized double-blind parallel groups. Sixty MDD patients are enrolled in the study from December 2016 to May 2018.Random allocation software was used for random sequence generation. The random allocation process was carried out by a researcher blinded to the random sequence in order to avoid bias in this field. Sequentially numbered, sealed,opaque envelopes (SNOSE) technique was used to hide it.
Settings and conduct
The study is conducted at Atieh Clinical Neuroscience Center. Participants receive treatment for 10 sessions after being assigned to the intervention group. Before starting the treatment, the participants perform the Snaith-Hamilton Pleasure Scale (SHAPS) and the Hamilton Depression Rating Scale (HDRS) at baseline and during the tenth session for clinical evaluation. qEEG will be taken from the participants to check the anhedonia and ruminantion networks at baseline and treatment completion.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Outpatients male and female with the range of 18-70 years of age, The diagnosis of Major depressive disorder (MDD) according to Diagnostic and Statistical Manual of Mental Disorders (DSM-V), Having beck depression inventory (BDI)>14, Having stable symptoms as defined by not requiring a change in medication for at least 4 weeks, Completion of consent form,Being under supervision of a psychiatrist. exclusion criteria:The history of rTMS treatment for any reason, having cardiac pacemaker,The risk of seizure with any reasons, pregnancy,High risk of suicide,Intracranial implant and other ferromagnetic materials close to the head
Intervention groups
There are 4 intervention groups in this study. The first group received classical cognitive-behavioral therapy, the second group received religious cognitive-behavioral therapy; the third group received rTMS and the fourth group received sham rTMS. In the control group, the stimulation parameters are similar to the actual TMS group, except that the coil angel is 90 ° and perpendicular to the head.
Main outcome variables
Anhedonia; Rumination,
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20100615004191N3
Registration date:2018-02-06, 1396/11/17
Registration timing:registered_while_recruiting
Last update:2018-02-06, 1396/11/17
Update count:2
Registration date
2018-02-06, 1396/11/17
Registrant information
Name
Reza Kazemi
Name of organization / entity
University of Tehran
Country
Iran (Islamic Republic of)
Phone
+98 21 8401 2128
Email address
rezakazemi@ut.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2016-12-21, 1395/10/01
Expected recruitment end date
2018-06-21, 1397/03/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The comparison of effectiveness of religious cognitive behavior therapy and classic cognitive behavior therapy and repetitive transcranial magnetic stimulation (rTMS) on anhedonia, rumination with their related neural circuits in patients with major depression
Public title
The comparison of effectiveness of cognitive behavior therapy and repetitive transcranial magnetic stimulation (rTMS) on anhedoni and rumination in patients with major depression
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Outpatients male and female with the range of 18-65 years of age
The diagnosis of Major depressive disorder according to DSM-V
Having BDI>14
Having stable symptoms as defined by not requiring a change in medication for at least 4 weeks
Completion of consent form
Being under supervision of a psychiatrist
Exclusion criteria:
The history of rTMS treatment for any reason
Cardiac pacemaker
The risk of seizure with any reasons
Pregnancy
High risk of suicide
Intracranial implant and other ferromagnetic materials close to the head
Age
From 18 years old to 70 years old
Gender
Both
Phase
N/A
Groups that have been masked
Participant
Outcome assessor
Sample size
Target sample size:
60
Randomization (investigator's opinion)
Randomized
Randomization description
Random allocation software was used for random sequence generation. The random allocation process was carried out by a researcher blinded to the random sequence in order to avoid bias in this field. SNOSE technique was used to hide it.
Blinding (investigator's opinion)
Double blinded
Blinding description
In this study, participants and outcome evaluators are blinded to the study groups. The outcome evaluator performs the evaluation without knowing which intervention group the participant belongs to. According to the explanations stated in the informed consent, the participants are told that they are randomly assigned to the intervention groups and, if they are in the control group, after the completion of the test, they will undergo the same number of sessions considered for the other patients. In the control group, the participant will receive the sham TMS. That is, all the parameters are the same as the actual TMS group, except that coil angle is different. Therefore, the participants are blinded to the type of treatment they receive.
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Iran University of Medical Sciences
Street address
Iran University of Medical Sciences, Shahid Hemmat Highway
City
Tehran
Province
Tehran
Postal code
۱۴۴۹۶۱۴۵۳۵
Approval date
2018-01-22, 1396/11/02
Ethics committee reference number
IR.IUMS.REC.1396.0339
Health conditions studied
1
Description of health condition studied
major depression disorder
ICD-10 code
F33
ICD-10 code description
Major depressive disorder, recurrent
Primary outcomes
1
Description
Anhedonia
Timepoint
baseline, ten session
Method of measurement
Snaith-Hamilton Pleasure Scale (SHAPS)
2
Description
Rumination
Timepoint
baseline, ten session
Method of measurement
Ruminative Response Scale (RRS)
3
Description
Anhedonia network
Timepoint
baseline, ten session
Method of measurement
EEG
4
Description
default mode network
Timepoint
baseline, ten session
Method of measurement
EEG
Secondary outcomes
1
Description
Score of depression
Timepoint
baseline, ten session
Method of measurement
Hamilton Depression Rating Scale
2
Description
score of anxiety
Timepoint
baseline, ten session
Method of measurement
Hamilton Anxiety Rating Scale
Intervention groups
1
Description
Intervention group: Repetitive transcranial magnetic stimulation
Intervention group: Religious based cognitive behavior therapy
Category
Treatment - Other
4
Description
Control group: Sham repetitive transcranial magnetic stimulation
Category
Placebo
Recruitment centers
1
Recruitment center
Name of recruitment center
Atieh Clinical Neuroscience Center
Full name of responsible person
Reza Kazemi
Street address
No 23,Vali-nezhad St, Above of vanak Sq
City
Tehran
Province
Tehran
Postal code
1969713663
Phone
+98 21 8401 2138
Fax
+98 21 8401 2101
Email
rezakazemi@ut.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Atieh Clinical Neuroscience Center
Full name of responsible person
Reza Rostami
Street address
No 23, Vali-nezhad St, Above of vanak Sq
City
Tehran
Province
Tehran
Postal code
1969713663
Phone
+98 21 8401 2138
Fax
+98 21 8401 2101
Email
rrostami@ut.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Atieh Clinical Neuroscience Center
Proportion provided by this source
100
Public or private sector
Private
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Persons
Person responsible for general inquiries
Contact
Name of organization / entity
Atieh Clinical Neuroscience Center
Full name of responsible person
Reza Kazemi
Position
Vice president of research
Latest degree
Ph.D.
Other areas of specialty/work
Psychology
Street address
No 23, Vali-nezhad St, Above of vanak Sq
City
Tehran
Province
Tehran
Postal code
1969713663
Phone
+98 21 8401 2138
Fax
+98 21 8401 2101
Email
rezakazemi@ut.ac.ir
Person responsible for scientific inquiries
Contact
Name of organization / entity
Atieh Clinical Neuroscience Center
Full name of responsible person
Reza Kazemi
Position
Vice president of research
Latest degree
Ph.D.
Other areas of specialty/work
Psychology
Street address
No 23, Vali-nezhad St, Above of vanak Sq
City
Tehran
Province
Tehran
Postal code
1969713663
Phone
+98 21 8401 2138
Fax
+98 21 8401 2101
Email
rezakazemi@ut.ac.ir
Person responsible for updating data
Contact
Name of organization / entity
Atieh Clinical Neuroscience Center
Full name of responsible person
Reza Kazemi
Position
Vice president of research
Latest degree
Ph.D.
Other areas of specialty/work
Psychology
Street address
No 23, Vali-nezhad St, Above of vanak Sq
City
Tehran
Province
Tehran
Postal code
1969713663
Phone
+98 21 8401 2138
Fax
+98 21 8401 2101
Email
rezakazemi@ut.ac.ir
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Title and more details about the data/document
The information on the main outcome of the study can be shared.
When the data will become available and for how long
Access time: one year after the release of the results
To whom data/document is available
The researchers working in the academic institutions
Under which criteria data/document could be used
The study data is available for writing meta-analysis.
From where data/document is obtainable
To receive the data, the principal researcher of the project must be contacted via email
Reza Kazemi
email:rezakazemi@ut.ac.ir
What processes are involved for a request to access data/document
After receiving the application for documentation, if the conditions are met, the documentation will be submitted to the applicant by the principal researcher within a week